S 1097 — Interagency Patent Coordination and Improvement Act of 2025
Congress 119
Latest action: — Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Sponsors
- Tillis, Thomas (R, NC-S) — cosponsor
Lobbied by (6)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | RADIUS ADVOCACY, LLC | COUNCIL FOR INNOVATION PROMOTION (C4IP) | $50,000 | S.1097 |
| 1st Quarter - Report | 2026 first_quarter | BLUECROSS BLUESHIELD OF TENNESSEE | BLUECROSS BLUESHIELD OF TENNESSEE | — | S1097 |
| 1st Quarter - Report | 2026 first_quarter | MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000 | S. 1097 |
| 1st Quarter - Report | 2026 first_quarter | ASSOCIATION OF THE UNITED STATES ARMY, (INC.) | ASSOCIATION OF THE UNITED STATES ARMY, (INC.) | — | S. 1097 |
| 1st Quarter - Report | 2026 first_quarter | FAEGRE DRINKER BIDDLE & REATH LLP | TEVA PHARMACEUTICALS USA, INC. | $60,000 | S 1097 |
| 1st Quarter - Report | 2026 first_quarter | ELITE STRATEGIC SERVICES | CONSERVATIVES FOR PROPERTY RIGHTS | $25,000 | S. 1097 |
Action timeline
- — Read twice and referred to the Committee on the Judiciary. (text: CR S1804-1805)
- · 10000 — Introduced in Senate
- — Committee on the Judiciary. Ordered to be reported with amendments favorably.
- — Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
- — Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- · 14000 — Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
Text versions
Connected on the graph
Inbound (7)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Tillis, Thomas | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2026-01-01 | ASSOCIATION OF THE UNITED STATES ARMY, (INC.) | lobbies_on_bill | — | S. 1097 | lobbying_bill_mention |
| 2026-01-01 | CONSERVATIVES FOR PROPERTY RIGHTS | lobbies_on_bill | — | S. 1097 | lobbying_bill_mention |
| 2026-01-01 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | lobbies_on_bill | — | S. 1097 | lobbying_bill_mention |
| 2026-01-01 | TEVA PHARMACEUTICALS USA, INC. | lobbies_on_bill | — | S 1097 | lobbying_bill_mention |
| 2026-01-01 | BLUECROSS BLUESHIELD OF TENNESSEE, INC. | lobbies_on_bill | — | S1097 | lobbying_bill_mention |
| 2026-01-01 | COUNCIL FOR INNOVATION PROMOTION (C4IP) | lobbies_on_bill | — | S.1097 | lobbying_bill_mention |
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2025-01-03 | referred_to_committee | Senate Judiciary Committee | — | congress-committee |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Tillis, Thomas (R, senate NC) | cosponsor | 0 | — | 1 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | 1 | $90,000 | 0 | $0 | $90,000 |
| 2 | TEVA PHARMACEUTICALS USA, INC. | 1 | $60,000 | 0 | $0 | $60,000 |
| 3 | COUNCIL FOR INNOVATION PROMOTION (C4IP) | 1 | $50,000 | 0 | $0 | $50,000 |
| 4 | CONSERVATIVES FOR PROPERTY RIGHTS | 1 | $25,000 | 0 | $0 | $25,000 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
1 predicted yes (0%) · 266 predicted no (49%) · 276 unknown (51%)
By party: · R: 1 yes / 0 no / 276 unknown · D: 0 yes / 263 no · I: 0 yes / 3 no
1 high-confidence positions (voted + sponsor + cosponsor)
- Tillis, Thomas (R · senate · NC) · cosponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-17 · cosponsored by Tillis, Thomas (cosponsor) · sponsorship
- 2026-01-01 · lobbied on by ASSOCIATION OF THE UNITED STATES ARMY, (INC.) (s. 1097) · lobbying_bill_mention
- 2026-01-01 · lobbied on by COUNCIL FOR INNOVATION PROMOTION (C4IP) (s.1097) · lobbying_bill_mention
- 2026-01-01 · lobbied on by CONSERVATIVES FOR PROPERTY RIGHTS (s. 1097) · lobbying_bill_mention
- 2026-01-01 · lobbied on by TEVA PHARMACEUTICALS USA, INC. (s 1097) · lobbying_bill_mention
- 2026-01-01 · lobbied on by BLUECROSS BLUESHIELD OF TENNESSEE, INC. (s1097) · lobbying_bill_mention
- 2026-01-01 · lobbied on by THE CAMPAIGN FOR SUSTAINABLE RX PRICING (s. 1097) · lobbying_bill_mention
- 2025-01-03 · was referred to Senate Judiciary Committee · congress-committee